COMF and its active components quercetin, kaempferol, isorhamnetin, luteolin and apigenin could regulate AKT1, VEGFA and IL-6 mRNA levels and improve the dysregulation of PI3K-AKT pathway signaling to intervene the inflammation and trauma manifested during the development of diabetes. The gene discussed is IL6; the disease is diabetes mellitus.